Takishima T, Sugimoto K, Asari Y, Kikuno T, Hirata M, Kakita A, Owada T
Department of Emergency and Critical Care Medicine, Kitasato University, School of Medicine, Sagamihara, Japan.
Nihon Geka Gakkai Zasshi. 1995 Jul;96(7):456-65.
To clarify the diagnostic reliability and significance of serum amylase levels (SAL) in the patients with pancreatic injury (PI), we reviewed 67 PIs. The elapsed time between injury and arrival of the hospital (ETAI) in the patients with normal SAL (1.3 +/- 0.2 hours, mean +/- SE) was significantly shorter than those with hyperamylasemia (5.8 +/- 0.9 hours). SAL on arrival significantly correlated to ETAI in the patients with type I (contusion) and type III injury (ductal injury). Among 45 patients who had arrived over 3 hours after injury, none showed normal SAL. Regardless of severity of PIs, one third of the patients showed normal SAL on arrival within 3 hours after injury. Among 23 patients treated conservatively, SAL in 14 patients (60.9%) normalized within 48 hours after injury, and these patients had no complications related to PIs. Three of remaining 9, who had prolonged hyperamylasemia over 48 hours, had pancreatic ductal branch injury or pseudocysts. This frequency was significantly different compared to that in the patients whose SAL normalized within 48 hours after injury. In conclusion, SAL is unreliable and insignificant to diagnose PIs within 3 hours after injury. Not to overlook the PIs serologically, it is important to determine SAL over 3 hours after injury especially in the patients having stable vital signs and to whom PIs are strongly suspected clinically.
为阐明血清淀粉酶水平(SAL)在胰腺损伤(PI)患者中的诊断可靠性及意义,我们回顾了67例胰腺损伤患者。SAL正常的患者从受伤到入院的时间间隔(ETAI)(1.3±0.2小时,均值±标准误)显著短于高淀粉酶血症患者(5.8±0.9小时)。I型(挫伤)和III型损伤(导管损伤)患者入院时的SAL与ETAI显著相关。在受伤后3小时以上入院的45例患者中,无一例SAL正常。无论胰腺损伤的严重程度如何,三分之一的患者在受伤后3小时内入院时SAL正常。在23例接受保守治疗的患者中,14例患者(60.9%)的SAL在受伤后48小时内恢复正常,且这些患者无胰腺损伤相关并发症。其余9例中,有3例高淀粉酶血症持续超过48小时,存在胰腺导管分支损伤或假性囊肿。这一频率与受伤后48小时内SAL恢复正常的患者相比有显著差异。总之,SAL在受伤后3小时内诊断胰腺损伤不可靠且意义不大。为避免血清学上漏诊胰腺损伤,受伤3小时后测定SAL很重要,尤其是对生命体征稳定且临床高度怀疑胰腺损伤的患者。